Thomas Bartlett

Many innovative ideas can become obscured when communicated, which was a significant challenge for Patient Blood Management #PBM as it was introduced to benefit those suffering from #anemia, in hopes of enabling surgery without the use of donated blood upon leaving the ER (Emergency Room). The PBM educational approach supports bloodless surgical procedures. To reduce this obscurity, we are simplifying the message and increasing awareness, benefiting #researchers, manufacturers, and healthcare practitioners. Most importantly, we are enhancing the patient experience and raising public awareness. We are confident that many global organizations, healthcare providers, and blood management surgical equipment manufacturers will support our efforts as we continue to be pioneers in building a bridge of engagement for public access, which will benefit this field of medicine. Remember our medical icons, just in case one day you need direction to the OR. #Bloodlines #BBTS #Blood #SABM

6

#ICYMI PathAI announced a new multifaceted #partnership with Quest Diagnostics designed to accelerate the adoption of digital and #AI #pathology innovations. https://lnkd.in/e8ES2-mA PathAI continues to operate as an independent entity, offering our services and capabilities to more partners and customers with more flexibility than before.    Here are the key takeaways: 1) Licensing of PathAI’s AISight™ IMS and Algorithm Portfolio  - Quest will license and deploy PathAI's AISight™ #digitalpathology image management system and algorithm portfolio to support their pathology laboratories across the USA. - Significant milestone in the adoption of digital pathology and AI. - Proof of the quality and value of our #data, #development, and #distribution capabilities.   2) Acquisition of PathAI Diagnostics (formerly Poplar Healthcare)  - Quest Diagnostics will acquire select assets of PathAI’s clinical anatomic pathology laboratory business, PathAI Diagnostics (formerly Poplar Healthcare) - PathAI transformed this lab over the past 3 years into a state-of-the-art digitized lab that will serve as Quest’s AI and digital R&D and solutions center. - PathAI will continue to operate as an independent entity, developing digital pathology and AI-powered tools for pathology laboratories and to advance drug development for #biopharma.   3) PathAI Selects Quest as a Preferred Partner for Biopharma Lab Business - PathAI may explore opportunities for mutual support and collaboration in algorithm product menu and IMS evolution. - Product and service enhancements will support all PathAI customers.   PathAI remains committed to accelerating the shift to digital & AI for pathology laboratories and biopharma’s shift towards digitalization.

166

2 Comments

The future of rare and specialty medication adherence lies in personalization powered by AI. Get a firsthand look at #Asembia24 - book a meeting with our experts for a customized assessment of your opportunities and potential impact. Change starts here: https://lnkd.in/gG53JNym 🔍

6

1 Comment

How do #digitalcare solutions ensure patient engagement? Find out in our latest case study featuring real-world data and insights from organizations consistently reporting extraordinarily high opt-in rates: https://lnkd.in/eMSMj9wi #patientengagement #qualityoutcomes

1

Learn how the Cloudbyz Vet eClinical Platform aligns with the latest FDA guidelines https://hubs.li/Q02ynDdD0

1

#Oncology clinical trials involve a host of challenges, including the need for highly targeted therapies for specific tumor types. Read the #QPS blog to learn about solutions to oncology #clinicaltrials challenges. For more, visit https://shorturl.at/dkoN7 or email info@qps.com.

6

The Team from SDC (Statistics & Data Corporation) sharing their #Eclinical and #DataManagement solutions to the audience at the #PCTSUMMIT in #BOSTON #ClinicalTrials #Biopharma #Biotech #AI #ML #Data #Biostats

17

Learn how the Cloudbyz Vet eClinical Platform aligns with the latest FDA guidelines https://hubs.li/Q02ynCmR0

1

Dive into Revenue Data Integrity with Kate Walsh, Director of Revenue Data. Discover how Trisus® Data Integrity can streamline your data processes and improve your bottom line. Swing by booth 549 at the HFMA Conference in Las Vegas! #DataIntegrity #HFMAConference

26

Dive into Revenue Data Integrity with Kate Walsh, Director of Revenue Data. Discover how Trisus® Data Integrity can streamline your data processes and improve your bottom line. Swing by booth 549 at the HFMA Conference in Las Vegas! #DataIntegrity #HFMAConference

6

🔬 Explore how Atempo's data management solution, Miria is impacting the future of Genomics Research in this new blog post ➡️ https://lnkd.in/ekfVcfq3   #lifesciences #Genomics #DataManagement 

9

On Monday, health technology and software company Komodo Health announced an expansion to its MapEnhance™ technology to "increas[e] the depth and volume of insights into social determinants of health (SDOH)". The company also announced that it would be forming new specialty data partnerships with GeneDx and COTA Healthcare. Read more in the full press release below. #KomodoHealth #Health #Healthcare #Medical #News

50

1 Comment

👀 Sales reps when Prospify Beta drops: ℹ️ (We’re building the 1st AI Agent to scale GTM sales to unexplored leads. Prospify analyzes companies’ sales pipelines, and scours the open web, surfacing 10 hyper-targeted prospects daily). 🔗 Become our champion, and get early access: https://lnkd.in/dCjWK4XA #AI #Agents #GTMAI #ML #Salesautomation

9

Blog: The #cancer #biomarker market is projected to continue its rapid expansion, with an expected value of $39,772.47 million in 2028 at a rate of 15.04%. https://hubs.la/Q02y99ng0 #healthcare #diagnostics

2

You’ve heard AI is changing medical science. Now, there’s an Open Source gene editor with the power to edit human DNA. https://lnkd.in/e6j2fJjK #OpenCRISPR-1 # Profluent #AI #HumanGenome #Healthcare #OIN

1